grant
SARS-CoV-2 Virology Core
Organization NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESLocation UNITED STATES
NIHUS FederalResearch GrantFY20250-11 years old2019 novel corona virus2019 novel coronavirus2019-nCoVAching musclesAcute NasopharyngitisAnimal ModelAnimal Models and Related StudiesAnimalsAnosmiaAnti-viral AgentsAvesAvianBatsBenignBiologyBirdsCOVID crisisCOVID epidemicCOVID infected patientCOVID pandemicCOVID patientCOVID positive patientCOVID-19COVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 immunityCOVID-19 infected patientCOVID-19 pandemicCOVID-19 patientCOVID-19 periodCOVID-19 positive patientCOVID-19 public health crisisCOVID-19 virusCOVID-19 yearsCOVID19 patientCOVID19 positive patientCOVID19 virusCV-19CamelsCase Fatality RatesCellular biologyCephalalgiaCephalgiaCephalodyniaCessation of lifeChildChild YouthChildren (0-21)ChinaChiropteraCirculationCitiesCivet CatsCivetsClinicalClinical ResearchClinical StudyClinical Treatment MoabCoV emergenceCoV-2CoV2Common ColdContainmentCore FacilityCoronaviridaeCoronavirusCoronavirus Infectious Disease 2019CoughingCountryCranial PainDNA Molecular BiologyDeathDevelopmentDiarrheaDiseaseDisease OutbreaksDisorderElderlyEmesisEnvironmentEvolutionFamilyFatigueFeverGenomeGoalsGustationHead PainHeadacheHospital AdmissionHospitalizationHumanImmunocompromisedImmunocompromised HostImmunocompromised PatientImmunosuppressed HostIndividualInfectionIntramural ProgramIntramural ResearchIntramural Research ProgramIntubationInvestigatorsLack of EnergyLinkMERS corona virusMERS coronavirusMERS virusMERS-CoVMainland ChinaMammaliaMammalsMiddle East Respiratory Syndrome Corona VirusMiddle East Respiratory Syndrome CoronavirusMiddle East Respiratory Syndrome VirusMiddle East Respiratory Syndrome-CoVMiddle East Respiratory VirusMiddle East Respiratory coronavirusMiddle Eastern Respiratory Syndrome Corona virusMiddle Eastern Respiratory Syndrome CoronavirusMiddle Eastern Respiratory Syndrome VirusMiddle Eastern Respiratory Syndrome-CoVModern ManMolecular BiologyMonoclonal AntibodiesMorbidityMorbidity - disease rateMuscle discomfortMuscle painMuscle pain/fibrositisMuscle sorenesssMyalgiaMyalgicMyodyniaMyoneuralgiaMyosalgiaNIAIDNamesNational Institute of Allergy and Infectious DiseaseNational Institutes of HealthNauseaNon-Polyadenylated RNAOrthocoronavirinaeOutbreaksPatientsPersonsPneumoniaPopulationProvincePublic HealthPyrexiaRNARNA Gene ProductsResearchResearch PersonnelResearchersRespiratory DiseaseRespiratory System DiseaseRespiratory System DisorderRibonucleic AcidSARSSARS VirusSARS corona virusSARS corona virus 2SARS coronavirusSARS coronavirus diseaseSARS-Associated CoronavirusSARS-CO-V2SARS-COVID-2SARS-CoVSARS-CoV diseaseSARS-CoV-1SARS-CoV-2SARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 immunitySARS-CoV-2 infected patientSARS-CoV-2 pandemicSARS-CoV-2 pathogenesisSARS-CoV-2 patientSARS-CoV-2 positive patientSARS-CoV2SARS-Related CoronavirusSARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicSARS-related corona virus 2SARS-related coronavirus 2SARSCoV2SamplingSevere Acute Respiratory CoronavirusSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory SyndromeSevere Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere Acute Respiratory Syndrome CoV diseaseSevere Acute Respiratory Syndrome VirusSevere Acute Respiratory Syndrome corona virusSevere Acute Respiratory Syndrome coronavirusSevere Acute Respiratory Syndrome coronavirus diseaseSevere Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 immunitySevere acute respiratory syndrome coronavirus 2 pandemicSevere acute respiratory syndrome related corona virus 2Shortness of BreathSore ThroatSourceStressSymptomsTasteTaste PerceptionTrainingTransmissionUnited States National Institutes of HealthVaccinationVaccinesVariantVariationVirusViverridaeVomitingWuhan coronavirusZoonosesZoonoticZoonotic Infectionadvanced ageanosphrasiaanti-viral compoundanti-viral drugsanti-viral medicationanti-viral therapeuticanti-viralsbeta CoVbeta coronavirusbetaCoVbetacoronaviruscell biologycorona viruscorona virus emergencecoronavirus disease 2019coronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 immunitycoronavirus disease 2019 infected patientcoronavirus disease 2019 pandemiccoronavirus disease 2019 patientcoronavirus disease 2019 positive patientcoronavirus disease 2019 public health crisiscoronavirus disease 2019 viruscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease infected patientcoronavirus disease pandemiccoronavirus disease patientcoronavirus disease positive patientcoronavirus disease-19coronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccoronavirus disease-19 patientcoronavirus disease-19 viruscoronavirus emergencecoronavirus infectious disease-19coronavirus patientdevelopmentalemergent CoVemergent corona virusemergent coronavirusemergent pandemicemerging CoVemerging corona virusemerging coronavirusemerging pandemicexperimentexperimental researchexperimental studyexperimentsfebrilefebrisgeriatricgustatory perceptiongustatory processinggustatory responsehCoV19head acheimmunity against COVID-19immunity against SARS-CoV-2immunity against Severe acute respiratory syndrome coronavirus 2immunity against coronavirus disease 2019immunity to COVID-19immunity to SARS-CoV-2immunity to Severe acute respiratory syndrome coronavirus 2immunity to coronavirus disease 2019immunosuppressed patientkidsloss of smellmAbsmodel of animalmonoclonal AbsmortalitynCoVnCoV2namenamednamingnew CoVnew corona virusnew coronavirusnew pandemicnovel CoVnovel corona virusnovel coronavirusnovel pandemicolfactory losspathogenpatient infected with COVIDpatient infected with COVID-19patient infected with SARS-CoV-2patient infected with coronavirus diseasepatient infected with coronavirus disease 2019patient infected with severe acute respiratory syndrome coronavirus 2patient with COVIDpatient with COVID-19patient with COVID19patient with SARS-CoV-2patient with coronavirus diseasepatient with coronavirus disease 2019patient with severe acute respiratory distress syndrome coronavirus 2respiratoryresponseseasonal coronavirusseasonal human coronavirussenior citizensevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicsevere acute respiratory syndrome coronavirus 2 infected patientsevere acute respiratory syndrome coronavirus 2 pathogenesissevere acute respiratory syndrome coronavirus 2 patientsevere acute respiratory syndrome coronavirus 2 positive patientsevere acute respiratory syndrome-CoVtaste processingtaste responsetranslational studytransmission processvirologyyoungsterβ CoVβ coronavirusβCoV
Description preview
Viruses of the Coronaviridae family are enveloped viruses that possess a large (30kb), single-stranded, positive sense, RNA genome that infect a large number of mammals (alpha and beta coronaviruses) and birds (gamma coronaviruses). Four different seasonal coronaviruses (two alpha coronaviruses, 229E and NL63, and two beta coronaviruses, OC43 and…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click